<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02104414</url>
  </required_header>
  <id_info>
    <org_study_id>13-0062</org_study_id>
    <nct_id>NCT02104414</nct_id>
  </id_info>
  <brief_title>Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy</brief_title>
  <official_title>Comparison of Rectal Infiltration of Exparel vs. 0.25% Bupivacaine With Epinephrine vs. Placebo for Analgesic Benefit Following Hemorrhoidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Luke's-Roosevelt Hospital Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Luke's-Roosevelt Hospital Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the quality and duration of pain relief after a
      hemorrhoidectomy, provided by locally administered liposomal bupivacaine versus bupivacaine
      hcl or control with saline. It is hypothesized that liposomal bupivacaine will provide more
      effective postoperative pain relief than both bupivacaine hcl and the control.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    low enrollment
  </why_stopped>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Operative Pain Control</measure>
    <time_frame>up to 4 days</time_frame>
    <description>The primary objective is to evaluate analgesia following local infiltration of 30 mL Exparel or the same volume of 0.25% bupivacaine HCl with epinephrine or normal saline. The intensity of pain will be measured using a numerical rating scale (NRS-11) in which 0 represents no pain, and 10 represents extreme pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Oxycodone Tablets Taken</measure>
    <time_frame>up to 4 days</time_frame>
    <description>Number of postoperative opioid consumption - oxycodone tablets (5mg each)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Opioid Consumption - Hydromorphone I.V</measure>
    <time_frame>1 hour and 2 hours post op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Postoperative Nausea and Vomiting</measure>
    <time_frame>up to 4 days</time_frame>
    <description>Number of participants with postoperative nausea and vomiting episodes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Pain During Bowel Movements</measure>
    <time_frame>Hourly from PACU arrival to discharge and Q4H from 10:00-22:00 postoperatively for 4 days</time_frame>
    <description>Number of participants with pain during postoperative bowel movements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Urinary Retention</measure>
    <time_frame>up to 4 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Hemorrhoid</condition>
  <arm_group>
    <arm_group_label>Exparel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine HCl with epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>30mL Normal Saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Exparel</intervention_name>
    <description>266 mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
    <arm_group_label>Exparel</arm_group_label>
    <other_name>Liposomal Bupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine HCl with Epinephrine</intervention_name>
    <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
    <arm_group_label>Bupivacaine HCl with epinephrine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>30mL Normal Saline</description>
    <arm_group_label>Normal Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing hemorrhoidectomy for grade 3 or 4 hemorrhoids who are
             English-speaking patients, 21-65 yr of age, ASA physical status I-III, BMI&lt;30

        Exclusion Criteria:

          -  contraindications to administration of local anesthesia (e.g., local anesthetic
             allergy), difficult airway (Mallampati&gt;2), psychiatric or cognitive disorders,
             pregnancy , and history of substance abuse or chronic opioid use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Shariat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Luke's-Roosevelt Hospital Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St.Luke's-Roosevelt Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>March 28, 2014</study_first_submitted>
  <study_first_submitted_qc>April 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2014</study_first_posted>
  <results_first_submitted>April 17, 2017</results_first_submitted>
  <results_first_submitted_qc>December 3, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 4, 2018</results_first_posted>
  <last_update_submitted>December 3, 2018</last_update_submitted>
  <last_update_submitted_qc>December 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liposomal Bupivacaine</keyword>
  <keyword>Exparel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Exparel</title>
          <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
        </group>
        <group group_id="P2">
          <title>Bupivacaine HCl With Epinephrine</title>
          <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
        </group>
        <group group_id="P3">
          <title>Normal Saline</title>
          <description>30mL Normal Saline</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exparel</title>
          <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
        </group>
        <group group_id="B2">
          <title>Bupivacaine HCl With Epinephrine</title>
          <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
        </group>
        <group group_id="B3">
          <title>Normal Saline</title>
          <description>30mL Normal Saline</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="2"/>
            <count group_id="B4" value="11"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.8" spread="14.61"/>
                    <measurement group_id="B2" value="40.75" spread="13.1"/>
                    <measurement group_id="B3" value="51.5" spread="9.19"/>
                    <measurement group_id="B4" value="44.54" spread="10.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post Operative Pain Control</title>
        <description>The primary objective is to evaluate analgesia following local infiltration of 30 mL Exparel or the same volume of 0.25% bupivacaine HCl with epinephrine or normal saline. The intensity of pain will be measured using a numerical rating scale (NRS-11) in which 0 represents no pain, and 10 represents extreme pain.</description>
        <time_frame>up to 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exparel</title>
            <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine HCl With Epinephrine</title>
            <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
          </group>
          <group group_id="O3">
            <title>Normal Saline</title>
            <description>30mL Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Post Operative Pain Control</title>
          <description>The primary objective is to evaluate analgesia following local infiltration of 30 mL Exparel or the same volume of 0.25% bupivacaine HCl with epinephrine or normal saline. The intensity of pain will be measured using a numerical rating scale (NRS-11) in which 0 represents no pain, and 10 represents extreme pain.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="1.33" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O3" value="7" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="1.0" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O3" value="2.5" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.75" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="6.5" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O3" value="5.5" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="4.5" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O3" value="4" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.25" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="5.0" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O3" value="3" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.67" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O2" value="3.0" lower_limit="0" upper_limit="10"/>
                    <measurement group_id="O3" value="2" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Oxycodone Tablets Taken</title>
        <description>Number of postoperative opioid consumption - oxycodone tablets (5mg each)</description>
        <time_frame>up to 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exparel</title>
            <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine HCl With Epinephrine</title>
            <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
          </group>
          <group group_id="O3">
            <title>Normal Saline</title>
            <description>30mL Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Oxycodone Tablets Taken</title>
          <description>Number of postoperative opioid consumption - oxycodone tablets (5mg each)</description>
          <units>tablets</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="2.28"/>
                    <measurement group_id="O2" value="2.67" spread="1.53"/>
                    <measurement group_id="O3" value="1.5" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="1.58"/>
                    <measurement group_id="O2" value="1.67" spread="0.58"/>
                    <measurement group_id="O3" value="2.5" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.52"/>
                    <measurement group_id="O2" value="1.5" spread="0.78"/>
                    <measurement group_id="O3" value="2.5" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="1.63"/>
                    <measurement group_id="O2" value="1" spread="0"/>
                    <measurement group_id="O3" value="1.5" spread="0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Opioid Consumption - Hydromorphone I.V</title>
        <time_frame>1 hour and 2 hours post op</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exparel</title>
            <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine HCl With Epinephrine</title>
            <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
          </group>
          <group group_id="O3">
            <title>Normal Saline</title>
            <description>30mL Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Opioid Consumption - Hydromorphone I.V</title>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.35" spread="0.47"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0.8" spread="0.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.6"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                    <measurement group_id="O3" value="0.6" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Postoperative Nausea and Vomiting</title>
        <description>Number of participants with postoperative nausea and vomiting episodes</description>
        <time_frame>up to 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exparel</title>
            <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine HCl With Epinephrine</title>
            <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
          </group>
          <group group_id="O3">
            <title>Normal Saline</title>
            <description>30mL Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Postoperative Nausea and Vomiting</title>
          <description>Number of participants with postoperative nausea and vomiting episodes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hour 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hour 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Pain During Bowel Movements</title>
        <description>Number of participants with pain during postoperative bowel movements</description>
        <time_frame>Hourly from PACU arrival to discharge and Q4H from 10:00-22:00 postoperatively for 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exparel</title>
            <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine HCl With Epinephrine</title>
            <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
          </group>
          <group group_id="O3">
            <title>Normal Saline</title>
            <description>30mL Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Pain During Bowel Movements</title>
          <description>Number of participants with pain during postoperative bowel movements</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Urinary Retention</title>
        <time_frame>up to 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exparel</title>
            <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
          </group>
          <group group_id="O2">
            <title>Bupivacaine HCl With Epinephrine</title>
            <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
          </group>
          <group group_id="O3">
            <title>Normal Saline</title>
            <description>30mL Normal Saline</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Urinary Retention</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="4"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>There were no adverse events</desc>
      <group_list>
        <group group_id="E1">
          <title>Exparel</title>
          <description>266mg/20mL Exparel (to be diluted with 10 mL sterile saline to make 30 mL)</description>
        </group>
        <group group_id="E2">
          <title>Bupivacaine HCl With Epinephrine</title>
          <description>75mg/30mL 0.25% Bupivacaine HCl with epinephrine</description>
        </group>
        <group group_id="E3">
          <title>Normal Saline</title>
          <description>30mL Normal Saline</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ali Shariat</name_or_title>
      <organization>Mount Sinai St. Luke's</organization>
      <phone>914-409-5023</phone>
      <email>alishariatmd@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

